Annual D&A
$12.00 K
+$2700.00+29.03%
31 December 2023
Summary:
Context Therapeutics annual depreciation & amortization is currently $12.00 thousand, with the most recent change of +$2700.00 (+29.03%) on 31 December 2023. CNTX annual D&A is now at all-time high.CNTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2800.00
+$200.00+7.69%
01 September 2024
Summary:
Context Therapeutics quarterly depreciation & amortization is currently $2800.00, with the most recent change of +$200.00 (+7.69%) on 01 September 2024. Over the past year, it has dropped by -$300.00 (-9.68%). CNTX quarterly D&A is now -12.50% below its all-time high of $3200.00, reached on 30 September 2022.CNTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$10.60 K
-$300.00-2.75%
01 September 2024
Summary:
Context Therapeutics TTM depreciation & amortization is currently $10.60 thousand, with the most recent change of -$300.00 (-2.75%) on 01 September 2024. Over the past year, it has dropped by -$2100.00 (-16.54%). CNTX TTM D&A is now -17.19% below its all-time high of $12.80 thousand, reached on 30 June 2023.CNTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +29.0% | -9.7% | -16.5% |
3 y3 years | - | +100.0% | +100.0% |
5 y5 years | - | - | - |
CNTX Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | -12.5% | -17.2% | |||
5 y | 5 years | at high | -12.5% | -17.2% | |||
alltime | all time | at high | -12.5% | -17.2% |
Context Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2800.00(+7.7%) | $10.60 K(-2.8%) |
June 2024 | - | $2600.00(0.0%) | $10.90 K(-5.2%) |
Mar 2024 | - | $2600.00(0.0%) | $11.50 K(-5.0%) |
Dec 2023 | $12.00 K(+29.0%) | $2600.00(-16.1%) | $12.10 K(-4.7%) |
Sept 2023 | - | $3100.00(-3.1%) | $12.70 K(-0.8%) |
June 2023 | - | $3200.00(0.0%) | $12.80 K(+2.4%) |
Mar 2023 | - | $3200.00(0.0%) | $12.50 K(+34.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | $9300.00(>+9900.0%) | $3200.00(0.0%) | $9300.00(+52.5%) |
Sept 2022 | - | $3200.00(+10.3%) | $6100.00(+110.3%) |
June 2022 | - | $2900.00(>+9900.0%) | $2900.00(>+9900.0%) |
Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2021 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
June 2021 | - | $0.00 | $0.00 |
FAQ
- What is Context Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Context Therapeutics?
- What is Context Therapeutics annual D&A year-on-year change?
- What is Context Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Context Therapeutics?
- What is Context Therapeutics quarterly D&A year-on-year change?
- What is Context Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Context Therapeutics?
- What is Context Therapeutics TTM D&A year-on-year change?
What is Context Therapeutics annual depreciation & amortization?
The current annual D&A of CNTX is $12.00 K
What is the all time high annual D&A for Context Therapeutics?
Context Therapeutics all-time high annual depreciation & amortization is $12.00 K
What is Context Therapeutics annual D&A year-on-year change?
Over the past year, CNTX annual depreciation & amortization has changed by +$2700.00 (+29.03%)
What is Context Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CNTX is $2800.00
What is the all time high quarterly D&A for Context Therapeutics?
Context Therapeutics all-time high quarterly depreciation & amortization is $3200.00
What is Context Therapeutics quarterly D&A year-on-year change?
Over the past year, CNTX quarterly depreciation & amortization has changed by -$300.00 (-9.68%)
What is Context Therapeutics TTM depreciation & amortization?
The current TTM D&A of CNTX is $10.60 K
What is the all time high TTM D&A for Context Therapeutics?
Context Therapeutics all-time high TTM depreciation & amortization is $12.80 K
What is Context Therapeutics TTM D&A year-on-year change?
Over the past year, CNTX TTM depreciation & amortization has changed by -$2100.00 (-16.54%)